Summary Information:
ENDRA Life Sciences Inc. Common Stock
NASDAQ:NDRA


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


ENDRA Life Sciences Inc. Common Stock
Exchange: NASDAQ
Symbol: NDRA
SEC CIK: 0001681682
Phone: 734-335-0468
3600 GREEN COURT
SUITE 350
ANN ARBOR MI 48105
CEO:
Price when page updated: 0.9779 Date: 2023-12-01
Company Website:
www.endrainc.com

_Description: ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with the over 1 million ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over 1 billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures.

IPO YEAR:
2017
Sector:
Health Care
Industry:
Medical Specialities
ADRTSO:

MarketCap:
8268068.00
Beta:
2.05907975262247
52 Week High:
3.1
52 Week Low:
0.7061
52 Week Change:
0.02581594435527013
Short Interest:

Short Date:

Shares Outstanding:
42165726
Dividend Rate:
0
Dividend Yield:
8.13%
ExDividend Date:

Latest EPS:

Latest EPS Date:
27 Oct 2022
Float:
0
return on Equity:
-99.00%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$4.564B
ttmEPS:
0
Revenue:
$25.476B
Gross Profit:

Cash:

Debt:

Institution Percent:
60.20%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.07%
Return on Assets:
4.50%
Return on Capital:

Profit Margin:
6.80%
Price to Sales:
3.26
Price To Book:
-
Short Ratio:
2.17
PE Ratio:
0
Employees:
18
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__ENDRA Life Sciences Inc. Common Stock [ NDRA ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01